MedTrace Logo

Efficacy Study of Atorvastatin to Treat Variant Angina

NCT00620204 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2009-04-06

No results posted yet for this study

Summary

The objective of this study is to evaluate effect of statin treatment for vasospastic angina.

Conditions

  • Angina Pectoris, Variant

Interventions

DRUG

atorvastatin

atorvastatin 40mg qd for 1 year

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hyun-chul Gwon, MD,PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620204 on ClinicalTrials.gov